Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 09/29/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces today that it has launched TSW Topicals (), a range of over-the-counter, topical pain relief products using an innovative blend of clinically proven organic ingredients such as menthol, curcumin, ginger and capsaicin to reduce inflammation and effectively relieve pain.
Products include solutions for muscle and joint pain, back pain, neuropathy/nerve pain and arthritis. TSW Pain, a topical pain relief cream for muscle and joint relief, is currently under testing to meet FDA requirements and Rising execs are confident it will hit the market sometime during Q4.
The Company also announces today a trial run of its Clinical Strength Peptide Serum for scar and skin repair. The serum produces visible results with an effective ingredient base and delivery system and Rising BioSciences is launching a sample run for a limited number of subscribers to our newsletter. All you have to do to reserve your sample is visit , scroll to the bottom of the home page and ''Subscribe'' to our newsletter while supplies last.
"We have received an overwhelmingly positive response to its trial run for TSW Pain and expect similar feedback for our clinical strength peptide serum," states Doug Bowes, Director of Brand Development.
As well, CEO Robert Weber has been working toward an official name and ticker change for Rising India, Inc. and has retained the services of the same attorney that assisted in successfully attaining the name and symbol change for sister company, PAO Group, Inc. (OTC: PAOG)
$RSII on Twitter for LIVE company updates!
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.
Image Available:
Image Available:
RISING INDIA CONTACT:
Investor Relations
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.09.2017 - 06:30 Uhr
Sprache: Deutsch
News-ID 1522626
Anzahl Zeichen: 1098
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 455 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum
"
steht unter der journalistisch-redaktionellen Verantwortung von
Rising India, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
